Saturday, September 28, 2019

Cancer Summit 2019


Study shows that combination of cediranib and olaparib proves effective and safe for women with heavily pretreated, platinum-resistant ovarian cancer. To explore more oncology, PS: https://cancer-oncology.pulsusconference.com/



No comments:

Post a Comment